SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-23-003523
Filing Date
2023-03-16
Accepted
2023-03-16 15:57:48
Documents
99
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_123122.htm   iXBRL 10-K 1592038
2 CONSENT OF BDO USA, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 3146
3 CERTIFICATION BY CEO PURSUANT TO SECTION 302 ex31-1.htm EX-31.1 10065
4 CERTIFICATION BY CFO PURSUANT TO SECTION 302 ex31-2.htm EX-31.2 9967
5 CERTIFICATION BY CEO PURSUANT TO SECTION 906 ex32-1.htm EX-32.1 4656
6 CERTIFICATION BY CFO PURSUANT TO SECTION 906 ex32-2.htm EX-32.2 4685
  Complete submission text file 0001387131-23-003523.txt   8405125

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE admp-20221231.xsd EX-101.SCH 73802
8 XBRL CALCULATION FILE admp-20221231_cal.xml EX-101.CAL 128104
9 XBRL DEFINITION FILE admp-20221231_def.xml EX-101.DEF 316218
10 XBRL LABEL FILE admp-20221231_lab.xml EX-101.LAB 605139
11 XBRL PRESENTATION FILE admp-20221231_pre.xml EX-101.PRE 487674
93 EXTRACTED XBRL INSTANCE DOCUMENT admp-10k_123122_htm.xml XML 1033508
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36242 | Film No.: 23738657
SIC: 2834 Pharmaceutical Preparations